FDA mandates “black box” for Celebrex, pulls Bextra off market
April 7, 2005 Drug giant Pfizer’s two blockbuster Cox-2 inhibitor drugs, Celebrex and Bextra, were both cited by the Food and Drug Administration for safety problems, particularly for long term users. Last Thursday